Document is current
Any future updates will be listed below
-
Authors
Moore, Landon L.
Qu, Dongfeng
Chandrekesan, Parthasarathy
Pitts, Kamille
May, Randal
Anderson, Byron E.
Brown, Milton L.
Houchen, Courtney W.
-
Funding
Funding for this research was provided by:
Presbyterian Health Foundation (Bridge)
Presbyterian Health Foundation (Bridge)
Presbyterian Health Foundation (Bridge)
Presbyterian Health Foundation (Bridge)
Presbyterian Health Foundation (Bridge)
National Cancer Institute (NCI) Cancer Center Support Grant (P30CA225520)
National Cancer Institute (NCI) Cancer Center Support Grant (P30CA225520)
National Cancer Institute (NCI) Cancer Center Support Grant (P30CA225520)
National Cancer Institute (NCI) Cancer Center Support Grant (P30CA225520)
National Cancer Institute (NCI) Cancer Center Support Grant (P30CA225520)
National Cancer Institute (NCI) Cancer Center Support Grant (P30CA225520)
National Cancer Institute (NCI) Cancer Center Support Grant (P30CA225520)
Oklahoma Tobacco Settlement Endowment Trust (R23-02)
Oklahoma Tobacco Settlement Endowment Trust (R23-02)
Oklahoma Tobacco Settlement Endowment Trust (R23-02)
Oklahoma Tobacco Settlement Endowment Trust (R23-02)
Oklahoma Tobacco Settlement Endowment Trust (R23-02)
- License Information
-
More Information
Article History
Received: 24 February 2025
Accepted: 10 September 2025
First Online: 14 October 2025
Declarations
:
: Courtney W. Houchen has an ownership interest in COARE Holdings, Inc., and M.L.B. is a co-founder of Trocar Pharmaceuticals and of Shuttle Pharmaceuticals. The remaining authors declare that they have no competing interests.
